Confronto

Pasireotid vs. Vasopressin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

396091-73-9

nessun dato

Peso molecolare

1047.21 g/mol

1084.23 g/mol

Emivita

nessun dato

Sequenza

nessun dato

Meccanismo d'azione

Pasireotid

Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.

Vasopressin

Vasopressin binds V1 receptors (vasoconstriction, raising vascular resistance) and V2 receptors (renal water reabsorption via aquaporin channels). This raises blood pressure and acts antidiuretically. Desmopressin is the V2-selective synthetic analog.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Pasireotid	Vasopressin
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Pasireotid and Vasopressin?: Pasireotid is classified as "Ricerca (altro)", while Vasopressin is classified as "Ricerca (altro)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Vasopressin: Vasopressin (arginine vasopressin, antidiuretic hormone/ADH) is a cyclic nonapeptide hormone that regulates water balance and vascular tone. As Vasostrict it is approved to raise blood pressure in vasodilatory shock. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Pasireotid or Vasopressin?: The highest available evidence level is "RCT sull'uomo" for Pasireotid and "RCT sull'uomo" for Vasopressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Pasireotid and Vasopressin in Germany and the United States?: Germania: Pasireotid — Su prescrizione, Vasopressin — Su prescrizione. Stati Uniti: Pasireotid — Su prescrizione, Vasopressin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Pasireotid

Vasopressin

Germania

Su prescrizione

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Pasireotid and Vasopressin?

Pasireotid is classified as "Ricerca (altro)", while Vasopressin is classified as "Ricerca (altro)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Vasopressin: Vasopressin (arginine vasopressin, antidiuretic hormone/ADH) is a cyclic nonapeptide hormone that regulates water balance and vascular tone. As Vasostrict it is approved to raise blood pressure in vasodilatory shock. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Pasireotid or Vasopressin?

The highest available evidence level is "RCT sull'uomo" for Pasireotid and "RCT sull'uomo" for Vasopressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Pasireotid and Vasopressin in Germany and the United States?

Germania: Pasireotid — Su prescrizione, Vasopressin — Su prescrizione. Stati Uniti: Pasireotid — Su prescrizione, Vasopressin — Su prescrizione. These are factual summaries with source and review date on the individual pages.